BUZZ-Sera Prognostics falls on stock offering news

Reuters2025-02-11

** Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity

** Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size

** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval

** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC

** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG

** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2510818496?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-11 05:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510818496","market":"us","top_or_hot":-1,"title":"BUZZ-Sera Prognostics falls on stock offering news","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Sera Prognostics falls on stock offering news</title></head><body><p>** Sera Prognostics Inc's <span>SERA.O</span> down 7.6% in extended trading to $4.11 as it looks to raise equity</p><p>** Salt Lake City-based women's health co <span>commences</span> offering comprising stock and pre-funded warrants without disclosing deal size</p><p>** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval</p><p>** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC</p><p>** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG</p><p>** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Sera Prognostics falls on stock offering news</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Sera Prognostics falls on stock offering news\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-11 05:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Sera Prognostics falls on stock offering news</title></head><body><p>** Sera Prognostics Inc's <span>SERA.O</span> down 7.6% in extended trading to $4.11 as it looks to raise equity</p><p>** Salt Lake City-based women's health co <span>commences</span> offering comprising stock and pre-funded warrants without disclosing deal size</p><p>** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval</p><p>** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC</p><p>** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG</p><p>** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nL6N3P10PT:1","article_id":"2510818496","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510818496","pubTimestamp":1739223165,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Sera Prognostics falls on stock offering news** Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity** Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4127":"投资银行业与经纪业","JEF":"杰富瑞","BK4139":"生物科技","SERA":"Sera Prognostics, Inc."},"translate_title":"BUZZ-Sera Prognostics因股票发行消息而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SERA":0.9,"JEF":0.9},"content_text":"BUZZ-Sera Prognostics falls on stock offering news** Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity** Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%(Lance Tupper is a Reuters market analyst. The views expressed are his own)((lance.tupper@tr.com 1-646-279-6380))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2510818496","isCrawlerRequest":true}